Stock DGX QUEST DIAGNOSTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Quest Diagnostics Incorporated Stock

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-12-06 pm EST 		5-day change 1st Jan Change
157.35 USD -0.74% Intraday chart for Quest Diagnostics Incorporated -3.26% +14.12%
Dec. 04 Quest Diagnostics Incorporated Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-04-2024 03:00 PM
Dec. 03 Quest Diagnostics Launches Health Coaching on Questhealth.com to Help Individuals Take Control of Their Health CI

Valuation: Quest Diagnostics Incorporated

Capitalization 17.56B 16.62B 15.41B 13.78B 24.83B 1,487B 27.49B 192B 70.87B 611B 65.97B 64.51B 2,633B P/E ratio 2024 *
20x
P/E ratio 2025 * 17.8x
Enterprise value 22.57B 21.36B 19.8B 17.71B 31.91B 1,912B 35.33B 246B 91.09B 785B 84.8B 82.91B 3,384B EV / Sales 2024 *
2.3x
EV / Sales 2025 * 2.07x
Free-Float
68.76%
Yield 2024 *
1.87%
Yield 2025 * 1.9%
More valuation ratios * Estimated data

Chart: Quest Diagnostics Incorporated

Dynamic Chart

Latest news: Quest Diagnostics Incorporated

Quest Diagnostics Incorporated Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-04-2024 03:00 PM Dec. 04
Quest Diagnostics Launches Health Coaching on Questhealth.com to Help Individuals Take Control of Their Health Dec. 03 CI
Quest Diagnostics Insider Sold Shares Worth $5,395,484, According to a Recent SEC Filing Dec. 02 MT
Quest Diagnostics Insider Sold Shares Worth $5,731,302, According to a Recent SEC Filing Dec. 02 MT
Baird Adjusts Price Target on Quest Diagnostics to $181 From $182, Keeps Outperform Rating Nov. 25 MT
Leerink Adjusts Price Target on Quest Diagnostics to $169 From $165, Maintains Market Perform Rating Nov. 22 MT
Augurex Life Sciences and Quest Diagnostics Collaborate to Improve Rheumatoid Arthritis Diagnosis and Management Nov. 15 CI
Quest Diagnostics Insider Sold Shares Worth $278,525, According to a Recent SEC Filing Oct. 30 MT
Piper Sandler Adjusts Price Target on Quest Diagnostics to $165 From $150, Maintains Neutral Rating Oct. 28 MT
Mizuho Adjusts Price Target on Quest Diagnostics to $174 From $160 Oct. 24 MT
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. Oct. 23 CI
Citigroup Adjusts Price Target on Quest Diagnostics to $185 From $165 Oct. 23 MT
Barclays Adjusts Price Target on Quest Diagnostics to $168 From $154 Oct. 23 MT
More news

Last Transcript: Quest Diagnostics Incorporated

Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference, Dec-04-2024 03:00 PM
Dec. 04
More transcripts

Analysts' recommendations: Quest Diagnostics Incorporated

Baird Adjusts Price Target on Quest Diagnostics to $181 From $182, Keeps Outperform Rating Nov. 25 MT
Leerink Adjusts Price Target on Quest Diagnostics to $169 From $165, Maintains Market Perform Rating Nov. 22 MT
Piper Sandler Adjusts Price Target on Quest Diagnostics to $165 From $150, Maintains Neutral Rating Oct. 28 MT
Mizuho Adjusts Price Target on Quest Diagnostics to $174 From $160 Oct. 24 MT
Citigroup Adjusts Price Target on Quest Diagnostics to $185 From $165 Oct. 23 MT
More recommendations

Press Releases: Quest Diagnostics Incorporated

Quest Diagnostics Fortifies Patient Data Privacy and Cybersecurity With Robust Safeguards and Ongoing Threat Mitigation Strategies Dec. 04 AQ
Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference Dec. 03 PR
Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health Dec. 03 PR
Parker Family Health Center Celebrates Expansion Nov. 26 AQ
Quest Diagnostics Declares Quarterly Cash Dividend Nov. 12 PR
More press releases

News in other languages: Quest Diagnostics Incorporated

RECOMENDACIONES DE LOS ANALISTAS UK/EE.UU: Tesla, Constellations Brands, Old Dominion, Stellantis, Lloyds... Jul. 05
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK: Ecolab, Texas Instruments, Cisco, Britvic, Shopify... May. 16
RECOMENDACIONES DE LOS ANALISTAS EE.UU.: Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Feb. 21
RECOMENDACIONES DE LOS ANALISTAS EE.UU.: Caterpillar, Eli Lilly, Intel, Caterpillar, Shopify, Snap, Meta, T-Mobile... Feb. 07
Recomendaciones de los analistas EE.UU./UK: Burberry Group, Blackrock, Deliveroo, Unitedhealth, JPMorgan Chase, Qualcomm, Sage... Jan. 15
More news

Quotes and Performance

1 day-0.74%
1 week-3.26%
Current month-3.26%
1 month+1.40%
3 months+2.89%
6 months+10.31%
Current year+14.12%
More quotes

Course Extremes

1 week
156.72
Extreme 156.72
162.95
1 month
155.78
Extreme 155.78
165.32
Current year
123.04
Extreme 123.04
165.32
1 year
123.04
Extreme 123.04
165.32
3 years
119.59
Extreme 119.59
174.16
5 years
73.02
Extreme 73.02
174.16
10 years
59.66
Extreme 59.655
174.16
More quotes

Managers and Directors: Quest Diagnostics Incorporated

Director TitleAgeSince
James Davis CEO
 Chief Executive Officer 61 2022-02-02
Sam Samad DFI
 Director of Finance/CFO 54 2022-07-10
Yuri Fesko CTO
 Chief Tech/Sci/R&D Officer - 2023-12-19
Manager TitleAgeSince
Gary Pfeiffer BRD
 Director/Board Member 74 2004-11-30
Timothy Ring BRD
 Director/Board Member 66 2011-12-06
James Davis CHM
 Chairman 61 2023-03-31
More insiders

ETFs: Quest Diagnostics Incorporated

Name Weight AuM 1st Jan change Investor Rating
AGF U.S. MARKET NEUTRAL ANTI-BETA FUND - USD ETF AGF U.S. Market Neutral Anti-Beta Fund - USD
14.84% 380 M€ +9.14% -
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD Hedged
2.17% 2 M€ -.--%
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD ETF First Trust AlphaDEX U.S. Health Care Sector Index ETF - CAD
2.05% 7 M€ +13.43%
More ETFs: Quest Diagnostics Incorporated

Other Healthcare Facilities & Services

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-0.74%-3.26%+16.62%-0.18%17.56B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
-0.09%-2.28%+26.69%+36.78%80.99B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-2.76%-7.62%-24.78%-40.32%69.58B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+1.26%+7.46%+1.91%+76.81%26.85B
NATERA, INC. Stock Natera, Inc.
+1.56%+2.31%+196.46%+98.99%22.66B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.88%+1.20%+16.91%-2.35%20.04B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-0.99%-3.56%+6.75%-19.60%19.45B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
0.00%+9.88%+22.45%-18.02%14.17B
DAVITA INC. Stock DaVita Inc.
-0.69%-3.56%+53.85%+56.95%13.14B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+0.03%-2.62%+100.03%+91.30%13.21B
Average -0.02%-0.18%+41.69%+28.04% 29.77B
Weighted average by Cap. +0.08%-1.69%+27.05%+19.31%
See all sector performances

Financials

2024 *2025 *
Net sales 9.83B 9.31B 8.63B 7.71B 13.9B 833B 15.39B 107B 39.68B 342B 36.94B 36.12B 1,474B 10.67B 10.09B 9.36B 8.37B 15.08B 903B 16.7B 116B 43.05B 371B 40.07B 39.18B 1,599B
Net income 910M 861M 798M 714M 1.29B 77.09B 1.42B 9.94B 3.67B 31.67B 3.42B 3.34B 136B 1B 948M 879M 786M 1.42B 84.81B 1.57B 10.93B 4.04B 34.85B 3.76B 3.68B 150B
Net Debt 5.01B 4.74B 4.4B 3.93B 7.08B 424B 7.84B 54.69B 20.22B 174B 18.82B 18.4B 751B 4.51B 4.27B 3.96B 3.54B 6.38B 382B 7.06B 49.25B 18.21B 157B 16.95B 16.57B 677B
More financial data * Estimated data

Company Profile

Logo Quest Diagnostics Incorporated
Quest Diagnostics Incorporated is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (3%).
Employees
44,000
Sector
Healthcare Facilities & Services
Calendar
2025-01-13 - Détachement de
More about the company

Quotes

Date Price Change Volume
24-12-06 157.35 $ -0.74% 951,373
24-12-05 158.52 $ -1.07% 757,005
24-12-04 160.24 $ -1.05% 508,440
24-12-03 161.94 $ +0.27% 673,140
24-12-02 161.51 $ -0.71% 788,348

Delayed Quote Nyse, December 06, 2024 at 04:00 pm EST

More quotes

Income Statement and Estimates

income-statement-evolution-chart QUEST-DIAGNOSTICS-INCORPO More financial data

Ratings

Trading Rating
Investor Rating
ESG Refinitiv
A-
surperformance-ratings-light-chart QUEST-DIAGNOSTICS-INCORPOMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
157.35USD
Average target price
167.29USD
Spread / Average Target
+6.32%
Consensus
Profit revisions
estimates-change-chart QUEST-DIAGNOSTICS-INCORPO Estimate revisions

Quarterly revenue - Rate of surprise

quality-estimates-chart QUEST-DIAGNOSTICS-INCORPO Company calendar
  1. Stock Market
  2. Equities
  3. DGX Stock